Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir...
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
About this item
Full title
Author / Creator
Aygen, Bilgehan , Demirturk, Nese , Yildiz, Orhan , Celen, Mustafa Kemal , Celik, Ilhami , Barut, Sener , Ural, Onur , Batirel, Ayse , Mistik, Resit , Simsek, Funda , Asan, Ali , Ersoz, Gulden , Turker, Nesrin , Bilgin, Huseyin , Kinikli, Sami , Karakecili, Faruk , Zararsiz, Gokmen , Department of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey , Department of Infectious Diseases and Clinical Microbiology, Erzincan University School of Medicine, Erzincan, Turkey , Department of Infectious Diseases and Clinical Microbiology, Selcuk University School of Medicine, Konya, Turkey , Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey , Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey , Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey , Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey , Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey , Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey , Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kartal Dr. Lutfu Kirdar Training and Research Hospital, Istanbul, Turkey , Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kayseri Training and Research Hospital, Kayseri, Turkey , Department of Biostatistics, Erciyes University School of Medicine, Kayseri, Turkey , Department of Infectious Diseases and Clinical Microbiology, Uludag University School of Medicine, Bursa, Turkey , Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey , Department of Infectious Diseases and Clinical Microbiology, Okmeydani Training and Research Hospital, Istanbul, Turkey and Department of Infectious Diseases and Clinical Microbiology, Afyon Kocatepe University School of Medicine, Afyonkarahisar, Turkey
Publisher
Turkey: AVES Yayincilik A.S
Journal title
Language
English
Formats
Publication information
Publisher
Turkey: AVES Yayincilik A.S
Subjects
More information
Scope and Contents
Contents
mbitasvir/paritaprevir/ritonavir (OMV/PTV/r) ± dasabuvir (DSV) ± ribavirin (RBV) combination has demonstrated excellent rates of sustained virologic response (SVR) and a very good safety profile in patients with the chronic hepatitis C virus (HCV) genotype 1 or 4 infections. We aimed to investigate the effectiveness and safety of OMV/PTV/r ± DSV ±...
Alternative Titles
Full title
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
Authors, Artists and Contributors
Author / Creator
Demirturk, Nese
Yildiz, Orhan
Celen, Mustafa Kemal
Celik, Ilhami
Barut, Sener
Ural, Onur
Batirel, Ayse
Mistik, Resit
Simsek, Funda
Asan, Ali
Ersoz, Gulden
Turker, Nesrin
Bilgin, Huseyin
Kinikli, Sami
Karakecili, Faruk
Zararsiz, Gokmen
Department of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey
Department of Infectious Diseases and Clinical Microbiology, Erzincan University School of Medicine, Erzincan, Turkey
Department of Infectious Diseases and Clinical Microbiology, Selcuk University School of Medicine, Konya, Turkey
Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey
Department of Infectious Diseases and Clinical Microbiology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey
Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey
Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey
Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey
Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kartal Dr. Lutfu Kirdar Training and Research Hospital, Istanbul, Turkey
Department of Infectious Diseases and Clinical Microbiology, Saglik Bilimleri University Kayseri Training and Research Hospital, Kayseri, Turkey
Department of Biostatistics, Erciyes University School of Medicine, Kayseri, Turkey
Department of Infectious Diseases and Clinical Microbiology, Uludag University School of Medicine, Bursa, Turkey
Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey
Department of Infectious Diseases and Clinical Microbiology, Okmeydani Training and Research Hospital, Istanbul, Turkey
Department of Infectious Diseases and Clinical Microbiology, Afyon Kocatepe University School of Medicine, Afyonkarahisar, Turkey
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7236650
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7236650
Other Identifiers
ISSN
1300-4948
E-ISSN
2148-5607
DOI
10.5152/tjg.2020.19197
